3524 results for «2026»
3524 results
Advances in left main bifurcation PCI and renal denervation
06 Oct 2022 – From AICT-ASIAPCR 2022
Discover more about treatment strategies and recent evidence for left main bifurcation, the latest Malaysian Working Group consensus statement on renal denervation, as well as reviewing patient-centred clinical judgement and individualised treatment plans.
Evolving approaches to planning and guiding of complex PCI with ultra-low contrast
06 Oct 2022 – From AICT-ASIAPCR 2022
In this session, presenters describe how to use IVUS and physiology in the assessment of left anterior descending and/or left circumflex ostium in distal left main disease. Discover in the second part the general principles and clinically validated strategies for ultralow contrast coronary angiography and zero...
Beginning with the end in mind - FFR vs. IVUS imaging
06 Oct 2022 – From AICT-ASIAPCR 2022
Consult this session if you want to explore different plaque modification techniques and technology and see how to maximise PCI outcome with IVUS imaging. Also assess when to select FFR to determine when to treat vs. IVUS to determine where and how to treat.
Cracking calcium: best practices to integrate intravascular lithotripsy into your calcium management algorithm
07 Oct 2022 – From AICT-ASIAPCR 2022
With this session, keep up to date on the evidence, trials and outcome data for intravascular lithotripsy in severely calcified lesions. Learn how to use this technique in real-world patients and understand its role in the treatment algorithm for severely calcified coronary lesions.
Sirolimus coated balloon: expanding the scope of coronary artery disease treatment
07 Oct 2022 – From AICT-ASIAPCR 2022
Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.
Precision PCI - Simplifying the complex - Learn from the masters
07 Oct 2022 – From AICT-ASIAPCR 2022
This session will help you better understand the influence of stent design, drug and polymer on the procedural short and long-term outcomes, the use of OCT in PCI of complex coronary lesions and the role, prevalence and diagnosis of microvascular dysfunction in patients with ischaemia and...
TAVI in complex scenarios
19 Nov 2023 – From PCR London Valves 2023
What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!
Controversies in atrioventricular valves - The Heart Team ring, Vol II
19 Nov 2023 – From PCR London Valves 2023
This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.
Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices
20 Nov 2023 – From PCR London Valves 2023
Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Tricuspid TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
Valve in valve - TAVI in SAV - Part 1
20 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in TAVI in SAV with this selection of cases: learn how to manage a degenerated surgical valve using a novel transcatheter heart valve, navigate low-contrast valve-in-valve scenarios in early bioprosthesis failure, witness the adaptability of TAVI valve-in-valve in a severely tortuous and horizontal...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
Mitral TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
Discover compelling cases in TEER with this selection of cases: encounter the complexities of severe mitral regurgitation post-aortic root aneurysm repair, the urgency of percutaneous intervention in acute mitral regurgitation due to papillary muscle rupture, the challenges of acutely decompensated heart failure following complicated surgical AVR,...
Valve embolism and displacement
20 Nov 2023 – From PCR London Valves 2023
Consult this session to learn innovative strategies and management approaches for valve embolism and displacement: navigate the complexities of challenging severe aortic regurgitation, confront unexpected global myocardial ischemia during TAVI, explore the difficulties of a TAVI procedure in a surgical aortic valve with Evolut FX, and more!
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
TAVI - Patient selection
20 Nov 2023 – From PCR London Valves 2023
Gain essential insights into TAVI patient selection through these selected abstract submissions from PCR London Valves 2023: explore the benefits of guideline-directed therapy for severe aortic stenosis, unravel the significance of subthreshold aortic valve calcium scores in patients with cardiac amyloidosis and aortic stenosis, delve into...
TAVI in challenging aortic anatomy
20 Nov 2023 – From PCR London Valves 2023
Explore TAVI in challenging aortic anatomy through this selection of cases: navigate strategies for crossing severely adverse calcific bicuspid aortic valves in horizontal aortas, witness TAVI adaptability in cases of severe aortic stenosis with situs inversus totalis, learn about the complexities of TAVI implantation in patients...
TAVI - New indications, techniques and devices - Part 2
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift overview of evolving TAVI indications and techniques: gain insights into thirty-day outcomes with Evolut FX, stratified by heart team risk, witness the 12-month follow-up of the Valvosoft first-in-man study, uncover sizing considerations in bicuspid tapered aortic valves undergoing TAVI from the...
